Moleculin Biotech Filing Effectiveness Notice
Ticker: MBRX · Form: EFFECT · Filed: Apr 15, 2026 · CIK: 0001659617
Sentiment: neutral
Topics: effectiveness, registration-statement, sec-filing
Related Tickers: MOLN
TL;DR
Moleculin Biotech's registration statement is now effective. $MOLN
AI Summary
Moleculin Biotech, Inc. filed an EFFECT form on April 15, 2026, indicating the effectiveness of a registration statement. The filing, with accession number 9999999995-26-001181, relates to Act 33 and has file number 333-294686. The company's business address is 5300 Memorial Drive, Suite 950, Houston, TX 77007.
Why It Matters
This filing signifies that a registration statement for Moleculin Biotech, Inc. has become effective, which is a crucial step for certain securities offerings or corporate actions.
Risk Assessment
Risk Level: low — This filing is a procedural notice of effectiveness and does not inherently introduce new financial or operational risks.
Key Numbers
- 2026-04-15 — Filing Date (Date the EFFECT filing was accepted by the SEC.)
- 2026-04-14 — Effectiveness Date (Date the registration statement became effective.)
Key Players & Entities
- Moleculin Biotech, Inc. (company) — Filer
- 9999999995-26-001181 (dollar_amount) — SEC Accession Number
- 2026-04-15 (dollar_amount) — Filing Acceptance Date
- 2026-04-14 (dollar_amount) — Effectiveness Date
- 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 (dollar_amount) — Mailing and Business Address
- 0001659617 (dollar_amount) — CIK Number
- 333-294686 (dollar_amount) — File Number
FAQ
What type of filing is this?
This is an EFFECT filing, which is a Notice of Effectiveness.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001181.
When did this filing become effective?
The filing became effective on 2026-04-14.
What is the CIK number for Moleculin Biotech, Inc.?
The CIK number for Moleculin Biotech, Inc. is 0001659617.
What is the File Number associated with this registration?
The File Number associated with this registration is 333-294686.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 15, 2026 regarding Moleculin Biotech, Inc. (MBRX).